FLT3 and acute myeloid leukemia: In summary, these findings enhanced our understanding of the potential therapeutic implications of targeting PHGDH in FLT3-ITD+ AML and the underlying mechanism may be related to the regulation of Bcl-2/Bax pathway by PHGDH.